Not currently approved for paediatric use
Limited data available on patients aged 65 years and older. Use in elderly should be cautious, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy. No dose adjustments needed in patients aged 65 years and older.
Contraindicated in use with pregnancy. Women of childbearing potential should be counseled on the need for effective contraception during treatment and for 6 days after stopping.
Contraindicated in use with breastfeeding.